CN Patent

CN111116476A — 制备抗肿瘤药物多拉米胺的方法

Assigned to Wuhan Jiuzhou Yumin Medical Technology Co ltd · Expires 2020-05-08 · 6y expired

What this patent protects

本发明涉及一种制备抗肿瘤药物多拉米胺的方法。本发明所述的方法，其经过一步Suzuki反应后，经脱保护，羟胺缩合和酰胺缩合反应后得到多拉米胺。本发明的反应步数少，每步反应产率较高且操作简便，因此整条路线的总收率较高，同时具有良好的实验操作性。

USPTO Abstract

本发明涉及一种制备抗肿瘤药物多拉米胺的方法。本发明所述的方法，其经过一步Suzuki反应后，经脱保护，羟胺缩合和酰胺缩合反应后得到多拉米胺。本发明的反应步数少，每步反应产率较高且操作简便，因此整条路线的总收率较高，同时具有良好的实验操作性。

Drugs covered by this patent

Patent Metadata

Patent number
CN111116476A
Jurisdiction
CN
Classification
—
Expires
2020-05-08
Drug substance claim
No
Drug product claim
No
Assignee
Wuhan Jiuzhou Yumin Medical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.